Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Otsuka Beijing Research Institute, explained in plain language.
This study is testing if a new oral pill (ASTX727) works as well as the standard intravenous (IV) drug (decitabine) for people with myelodysplastic syndromes (MDS), a serious disorder where the bone marrow doesn't make enough healthy blood cells. Researchers will compare how the …
Phase: PHASE1, PHASE2 • Sponsor: Otsuka Beijing Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC